On December 29, Alignment Healthcare’s Chief Information Officer, Robert L. Scavo, executed an open-market sale of 69,541 shares, generating approximately $1.3 million in proceeds. Following the transaction, Scavo retained 503,014 directly held shares, valued at roughly $9.53 million. The shares sold represented 12.2% of his post-transaction direct holdings and were all common stock, with no options, derivative instruments or indirect holdings involved.

This latest disposition was significantly larger than Scavo’s historical median sell-only event of 8,235 shares, though not his largest on record (he sold 100,863 shares in June 2025). The 12.2% stake reduction compares with a recent-period median of 4.91% per sale, reflecting a pattern of larger block sales as his available share balance has gradually declined over successive transactions.

Alignment Healthcare reported third-quarter revenue of $993.7 million, up 43.5% year-over-year, driven by a 26% increase in membership. The company delivered $32.4 million in adjusted EBITDA and raised full-year guidance across revenue, membership and profitability metrics. Over the trailing twelve months, revenue reached $3.64 billion, while net loss narrowed to $20.8 million, underpinning positive momentum in insurance premiums and service fee growth.

Over the past year, Alignment Healthcare shares have climbed 78%, reflecting investor confidence in the tech-enabled Medicare Advantage model and scalable membership growth. While Scavo’s sale may attract attention, it was executed under a non-discretionary plan to cover tax withholding obligations on vested performance share units. Investors should focus on the company’s sustained revenue acceleration, expanding margins and raised guidance rather than on tax-driven insider transactions.